AppsFromResearch
Markey Cancer Clinical Trials icon

Markey Cancer Clinical Trials

Evidence Tier:DOCUMENTED

Published in academic literature

For:Researchers & AcademicsClinicians & Healthcare ProfessionalsPatients & Caregivers

App Summary

The Markey Cancer Clinical Trials app is a reference tool for patients and researchers that aims to improve awareness of and access to cancer research by providing a searchable database of open clinical trials at the Markey Cancer Center. The associated research establishes that low patient awareness and the difficulty of finding appropriate studies are significant barriers to trial enrollment, which slows progress in cancer care. The authors conclude that by "democratizing" access to trial information, mobile technology has the potential to connect the right patient to the right trial, ultimately helping to advance cancer care.

App Screenshots

Markey Cancer Clinical Trials screenshot 1 of 8Markey Cancer Clinical Trials screenshot 2 of 8Markey Cancer Clinical Trials screenshot 3 of 8Markey Cancer Clinical Trials screenshot 4 of 8Markey Cancer Clinical Trials screenshot 5 of 8Markey Cancer Clinical Trials screenshot 6 of 8Markey Cancer Clinical Trials screenshot 7 of 8Markey Cancer Clinical Trials screenshot 8 of 8

Detailed Description

Functionality & Mechanism

Developed by the Markey Cancer Center, this clinical reference tool provides a searchable database of open oncology clinical trials. The interface facilitates customized searches that allow patients and researchers to browse available studies. Core modules permit users to view expanded trial details, save specific trials to a personalized list for quick reference, and share information with care teams. The system also delivers programmatic information about the Markey clinical trial program, centralizing access to institutional research opportunities.

Evidence & Research Context

  • Associated research highlights that low enrollment in oncology clinical trials, involving less than 5% of adult patients, is a critical barrier to advancing cancer care.
  • The app is identified in the scientific literature as an institutional mobile platform designed to improve access to and awareness of available trials.
  • Such platforms leverage mobile technology to bridge the informational gap between academic medical centers and community oncology settings.
  • The authors note that a primary limitation of institutional applications is their "center-centric" scope, restricting search results to trials conducted at a single institution.

Intended Use & Scope

This tool is designed for patients and clinical researchers seeking information on trials specifically at the Markey Cancer Center. Its primary utility is as a reference for identifying and saving potentially relevant local studies. The application does not provide a comprehensive, national database of all oncology trials and should not substitute for direct consultation with a clinical care team.

Studies & Publications

1 publication

Peer-reviewed research associated with this app.

Non-Evaluative Reference

Searching for clinical trials in oncology: finding a path through the maze

Desai et al. (2023) · Annals of Oncology

Referenced in academic literature; no direct evaluation of the app
Clinical trials are the cornerstone of progress in cancer care, yet participation remains critically low, with less than 5% of adult cancer patients in the US enrolling. This widespread under-enrollment, further exacerbated by the pandemic, leads to the early termination of nearly 20% of oncology trials. This article identifies the lack of patient awareness and the complexity of finding appropriate trials as major barriers to participation. To address this, the authors review the emerging landscape of mobile applications designed to "democratize" access to clinical trials. The text categorizes current solutions into commercial apps (e.g., CancerTrials App, MatchTrial) and institutional apps (e.g., Markey Cancer Clinical Trials, Carbone Cancer Center Clinical Trials). These platforms leverage smartphone technology to offer customized searches based on disease type, biomarkers, location, and patient demographics, effectively bridging the gap between academic research centers and community oncology settings. However, the authors note that current tools are often limited by "center-centric" databases or industry sponsorship biases. The article concludes that for mobile technology to truly move the needle on cancer outcomes, future applications must offer an unbiased, "Amazon Prime"-like experience—providing a comprehensive, sponsor-agnostic menu of options that connects the right patient to the right trial at the right time.
... Read More

Markey Cancer Clinical Trials

Free